Sir,

An 11-year-old girl was being treated elsewhere from the age of 5 years for nephrotic syndrome. She received prednisolone 30 mg per day until remission followed by tapering. She had several relapses during the last 5 years, and presented to us in nephrotic state. Her pulse rate and blood pressure were 78 bpm and 90/70 mmHg, respectively. Systemic examination was unremarkable. Investigations revealed blood urea: 12 mg/dL, serum creatinine: 0.7 mg/dL, serum proteins: 4.7 g/dL, serum albumin: 2.1 g/dL, 24 h urine protein: 4.5 g, serum cholesterol: 450 mg/dL, serum LDL: 267 mg/dL, serum HDL 60 mg/dL, serum VLDL: 158 mg/dL, serum triglycerides 615 mg/dL, hemoglobin: 12 g/dL. Renal biopsy revealed 11 glomeruli, and findings were consistent with minimal change. She received 65 mg of prednisolone in three divided doses per day according to the ISKDC protocol.\[[@ref1]\] After 3 weeks, she presented with multiple episodes of generalized tonic clonic seizures. She was afebrile, pulse rate was 160 bpm, blood pressure was 110/60 mmHg. Glasgow coma scale was 7/15. Cerebrospinal fluid analysis revealed 3 cells/hpf, glucose: 56 mg/dL, protein: 15 mg/dL. MRI brain showed bilateral asymmetrical T2, FLAIR hyperintense lesions in cortical and subcortical location of parieto-occipital, temporal lobes, bilateral thalami, and cerebellum suggestive of posterior reversible encephalopathy syndrome (PRES)\[[Figure 1](#F1){ref-type="fig"}\]. She was treated with antiepileptics and the dose of prednisolone was reduced to half. She recovered completely in 48 h.
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PRES, originally termed reversible posterior leukoencephalopathy syndrome\[[@ref2]\] presents with headache, seizures, visual changes, altered mental status, and occasionally focal neurologic signs.\[[@ref3]\] CT and MR imaging typically show symmetrically distributed areas of vasogenic oedema predominantly within the territories of the posterior circulation.\[[@ref3]\]

PRES is seen with a heterogeneous group of disorders.\[[@ref3]\] In renal disorders, it is reported with hemolytic the uremic syndrome, thrombotic thrombocytopenic purpura, as a complication of Cyclosporine and tacrolimus,\[[@ref3][@ref4]\] and acute poststreptococcal nephritis\[[@ref4]\] In patients with the nephrotic syndrome, the risk factors are administrationof cyclosporine, tacrolimus,\[[@ref4]\] methylprednisolone,\[[@ref5]\] hypertension and renal insufficiency.

However, nephrotic syndrome itself could be considered a predisposing condition for developing PRES in both adults and children.\[[@ref6]\] The key pathophysiological process of PRES is vasogenic edema.\[[@ref2]\] due to decreased intravascular oncotic pressure, increased permeability of intracerebral capillaries, and fluid overload. Drugs such as cyclosporine, tacrolimus, and methylprednisolone may induce vasogenic oedema by alterating sympathetic flow, cyclosporine-mediated release of endothelin, or endothelial dysfunction, while hypertension may also induce oedema due to autoregulation failure of the cerebral blood flow.
